glp-1 anesthesia guidelines 2025 RA guidance roundup 2025 ADS/ANZCA/GESA/NACOS clinical practice recommendations
Description
Cardiovascular health: Diet quality, fiber intake, and exercise strongly influence heart health
adult obesity rate has gradually dropped to 36.4% thus far in 2026, a statistically meaningful decline that continues to inversely track with increased usage of GLP-1 medicine nationally
These symptoms are typically most pronounced during initial weeks of therapy and can be minimised through gradual dose titration starting at the lowest available dose
16 lbs on Saxendathough individual results vary widely
Patients should be educated about warning signs that require professional assessment to ensure safety and appropriate management
